---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-074068"
form_type: "8-K"
ticker: "MXCT"
cik: "0001287098"
company_name: "MAXCYTE, INC."
filed_at: "2023-06-23T23:59:59+00:00"
generated_at: "2026-06-13T17:43:14.163239+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# MaxCyte stockholders approve Amended 2022 Equity Incentive Plan, adding ~6.1M new shares

## Summary
- Stockholders voted 67.4M For, 9.1M Against (92.3% approval) to amend the 2022 Equity Incentive Plan.
- Amendment adds 6,069,000 new shares plus shares from prior plans to the share reserve.
- Total shares available under the plan will include up to 37.2M shares for Incentive Stock Options.
- Three directors elected: Art Mandell, Stanley Erck, Patrick Balthrop; all received majority votes.
- Ratification of CohnReznick LLP as independent auditor for FY2023 also approved (83.1M For).

## SEC filing metadata
- accession: 0001104659-23-074068
- form_type: 8-K
- ticker: MXCT
- cik: 0001287098
- company_name: MAXCYTE, INC.
- filed_at: 2023-06-23T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1287098/000110465923074068/0001104659-23-074068-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1287098/000110465923074068/tm2319527d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-074068
- JSON: https://secwatch.observer/filing/0001104659-23-074068.json
- Plain text: https://secwatch.observer/filing/0001104659-23-074068.txt

## Key facts
- Shareholder Votes
  MAXCYTE, INC. shareholders approved Approval of the Amended 2022 Plan at the 2023-06-22 meeting.
  - Proposal: equity plan
  - Outcome: passed
  - Meeting: 2023-06-22
  source text: Proposal No. 2: Approval of the Amended 2022 Plan. The votes were cast as follows: Votes For Votes Against Abstained Approval of an amendment and restatement of the 2022 Equity Incentive Plan 67,398,179 9,101,146 217,247 Broker Non-Votes: 6,512,902
  evidence_url: https://www.sec.gov/Archives/edgar/data/1287098/000110465923074068/0001104659-23-074068-index.htm
- Shareholder Votes
  MAXCYTE, INC. shareholders approved Ratification of the appointment of CohnReznick LLP as independent registered public accounting firm at the 2023-06-22 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2023-06-22
  source text: Proposal No. 3: Ratification of the appointment of CohnReznick LLP as independent registered public accounting firm for the fiscal year ending December 31, 2023. The votes were cast as follows: Votes For Votes Against Abstained Ratification of appointment of CohnReznick LLP 83,086,872 5,981 136,621
  evidence_url: https://www.sec.gov/Archives/edgar/data/1287098/000110465923074068/0001104659-23-074068-index.htm
- Shareholder Votes
  MAXCYTE, INC. shareholders approved Election of three nominees to serve as directors until the 2026 annual meeting at the 2023-06-22 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2023-06-22
  source text: Proposal No. 1: Election of three nominees to serve as directors until the 2026 annual meeting of stockholders and until their respective successors are elected and qualified. The votes were cast as follows: Name Votes For Votes Withheld Art Mandell 43,059,349 33,657,223 Stanley C. Erck 45,186,194 31,530,378 Patrick J. Balthrop 76,115,643 600,929 Broker Non-Votes: 6,512,902 All nominees were elected.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1287098/000110465923074068/0001104659-23-074068-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.